MAPT and Alzheimer disease: Additionally, signals of AT8, AT100, and AT180 antibodies, which recognize phosphoepitopes that are abundant in pathological aggregated and filamentous Tau of Alzheimer’s disease, are elevated in Tau transgenic mice, in particular in PSD fractions31.